论文部分内容阅读
AIM:Induced pluripotent stem cells(iPSCs)hold great promise for the development of patient-specific therapies for cardiovascular disease.However,clinical translation will require preclinical optimization and validation of large animal iPSC models.In this
AIM: Induced pluripotent stem cells (iPSCs) hold great promise for the development of patient-specific therapies for cardiovascular disease. Yet, clinical translation will require preclinical optimization and validation of large animal iPSC models. This